Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jan 10, 2025

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Grindr Inc (Class A)	J. Michael Gearon	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	8,448,334	6,500,000	-		0	Common Stock
Grindr Inc (Class A)	J. Michael Gearon	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	7,090,959	7,090,959	-		0	Common Stock
Grindr Inc (Class A)	J. Michael Gearon	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	6,500,000	0	-		0	Common Stock
Grindr Inc (Class A)	J. Michael Gearon	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	6,500,000	7,090,958	-		0	Common Stock
Relay Therapeutics Inc	Sanjiv K. Patel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	1,105,000	1,105,000	-		-	Stock Option (Right to Buy)
Amarin Corp (ADR)	Steven B. Ketchum	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	663,878	663,878	-		-	Stock Option (right to buy)
Eledon Pharma Inc	David-Alexandre C. Gros	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	600,000	600,000	-		-	Stock Option (right to buy)
Grindr Inc (Class A)	J. Michael Gearon	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	590,958	590,958	-		0	Common Stock
Coherus Biosciences Inc	Dennis M. Lanfear	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	575,000	575,000	-		-	Stock Option (Right to Buy)
Amarin Corp (ADR)	Peter Fishman	SVP, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	440,475	440,475	-		-	Stock Option (Right to Buy)
Relay Therapeutics Inc	Donald A. Bergstrom	President, R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	400,000	400,000	-		-	Stock Option (Right to Buy)
SELLAS Life Sciences Grp Inc	Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	385,750	385,750	-		-	Stock Option (Right to Buy)
Global Net Lease Inc	Edward M. Weil	Director, CEO, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	308,989	734,053 (0%)	0%		0	Common Stock
Caribou Biosciences Inc	Sriram Ryali	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	300,000	300,000	-		-	Option to purchase Common Stock
Zymeworks BC Inc	Kenneth Galbraith	Director, Chair & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	288,000	288,000	-		-	Stock Option (Right to Buy)
Relay Therapeutics Inc	Brian R. Adams	Chief Legal Officer		10 Jan 2025	275,000	275,000	-		-	Stock Option (Right to Buy)
Relay Therapeutics Inc	Thomas Catinazzo	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	275,000	275,000	-		-	Stock Option (Right to Buy)
Relay Therapeutics Inc	Peter Rahmer	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	275,000	275,000	-		-	Stock Option (Right to Buy)
SELLAS Life Sciences Grp Inc	Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	257,000	615,132 (12%)	5%		0	Common Stock
Omega Healthcare Investors Inc	C. Taylor Pickett	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	250,489	635,201	-		-	Profits Interest Units
SELLAS Life Sciences Grp Inc	Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	243,900	859,032 (16%)	4%		0	Common Stock
Eledon Pharma Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	243,000	243,000	-		-	Stock Option (right to buy)
Omega Healthcare Investors Inc	C. Taylor Pickett	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	241,837	384,712	-		-	Profits Interest Units
Zymeworks BC Inc	Kenneth Galbraith	Director, Chair & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	192,000	192,000	-		-	Restricted Stock Unit
iBio Inc	Antonio Bernardino Guimaraes Parada	Director	Purchase of securities on an exchange or from another person at price $ 2.72 per share.	10 Jan 2025	183,823	183,823 (0%)	0%	2.7	499,999	Common Stock
Eledon Pharma Inc	Paul Sean Little	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	175,000	175,000	-		-	Stock Option (right to buy)
SELLAS Life Sciences Grp Inc	Dragan Cicic	SVP, Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	169,500	169,500	-		-	Stock Option (Right to Buy)
SELLAS Life Sciences Grp Inc	John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	169,500	169,500	-		-	Stock Option (Right to Buy)
Eledon Pharma Inc	Bryan E. Smith	General Counsel, Corporate Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	150,500	150,500	-		-	Stock Option (right to buy)
SELLAS Life Sciences Grp Inc	Dragan Cicic	SVP, Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	113,000	228,328 (4%)	2%		0	Common Stock
SELLAS Life Sciences Grp Inc	John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	113,000	217,762 (4%)	2%		0	Common Stock
Omega Healthcare Investors Inc	Robert O. Stephenson	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	106,633	267,750	-		-	Profits Interest Units
Spyre Therapeutics Inc	Michael Henderson	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	105,379	105,379 (0%)	0%		0	Common Stock
Omega Healthcare Investors Inc	Robert O. Stephenson	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	102,950	161,117	-		-	Profits Interest Units
Crinetics Pharma Inc	Isabel Kalofonos	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	100,000	100,000	-		-	Stock Option (Right to Buy)
Verastem Inc	Daniel Paterson	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	100,000	331,149 (0%)	0%		0	Common Stock
Bioventus Inc (Class A)	Robert E. Claypoole	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	93,750	93,750 (0%)	0%		0	Class A Common Stock
Bioventus Inc (Class A)	Robert E. Claypoole	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	93,750	281,250	-		-	Restricted Stock Units
Aeluma Inc	John K. Paglia	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	87,973	210,011	-		-	Stock Option
RF Ind Ltd	Robert D. Dawson	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	87,500	87,500	-		-	Stock Option (Right to Buy)
Aeluma Inc	Craig H. Ensley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	85,885	129,889	-		-	Stock Option
Aeluma Inc	Steven P. DenBaars	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	84,663	127,942	-		-	Stock Option
SELLAS Life Sciences Grp Inc	Dragan Cicic	SVP, Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	81,300	309,628 (6%)	1%		0	Common Stock
SELLAS Life Sciences Grp Inc	John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	81,300	299,062 (5%)	1%		0	Common Stock
Paychex Board Meeting	B. Thomas Golisano	Director, Ten Percent Owner	Gift of securities by or to the insider at price $ 139.88 per share.	10 Jan 2025	80,580	37,031,419 (10%)	0%	139.9	11,271,530	Common Stock
Zymeworks BC Inc	Jeffrey T.L. Smith	EVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	79,000	79,000	-		-	Stock Option (Right to Buy)
Zymeworks BC Inc	Paul Andrew Moore	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	79,000	79,000	-		-	Stock Option (Right to Buy)
Mobile infra Corp	Stephanie Hogue	Director, President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	78,125	78,125	-		-	Common Stock
Mobile infra Corp	Stephanie Hogue	Director, President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	78,125	156,250	-		-	Restricted Stock Units
Eledon Pharma Inc	Keith A. Katkin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	77,175	77,175	-		-	Stock Option (right to buy)
Eledon Pharma Inc	Paul Sean Little	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	75,000	75,000	-		-	Restricted Stock Units
Praxis Precision Medicines Inc	Marcio Souza	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	75,000	75,000	-		-	Stock Option (Right to Buy)
Alexandria Real Estate Equities Inc	Peter M. Moglia	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	70,593	296,732 (0%)	0%		0	Common Stock
374Water Inc Board Meeting	Yaacov Nagar	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.68 per share.	10 Jan 2025	69,570	37,050,752	-	0.7	47,586	Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 73.58 per share.	10 Jan 2025	68,644	203,476	-	73.6	5,051,045	Ordinary Shares
Global Net Lease Inc	Christopher J. Masterson	CFO, Secretary and Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	67,416	315,659 (0%)	0%		0	Common Stock
Eledon Pharma Inc	David-Alexandre C. Gros	Director, Chief Executive Officer		10 Jan 2025	66,500	66,500	-		-	Restricted Stock Units
Eledon Pharma Inc	Bryan E. Smith	General Counsel, Corporate Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	64,500	64,500	-		-	Restricted Stock Units
Global Net Lease Inc	Jesse Charles Galloway	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	61,798	164,273 (0%)	0%		0	Common Stock
Alphatec Holdings Inc	David P. Sponsel	EVP, SALES	Sale of securities on an exchange or to another person at price $ 10.71 per share.	10 Jan 2025	58,283	502,311 (0%)	0%	10.7	624,211	Common Stock
Genpact Ltd	N. V. Tyagarajan	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.38 per share.	10 Jan 2025	55,000	706,483 (0%)	0%	42.4	2,330,900	Common Shares
Zymeworks BC Inc	Jeffrey T.L. Smith	EVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	53,000	53,000	-		-	Restricted Stock Unit
Zymeworks BC Inc	Paul Andrew Moore	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	53,000	53,000	-		-	Restricted Stock Unit
Boston Omaha Corp (Class A)	Adam K. Peterson	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share.	10 Jan 2025	51,516	6,756,842	-	10	515,160	Class B Common Stock
Central Plains Bancshares Inc	Steven D. Kunzman	Director, President & CEO, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	50,000	50,000	-		-	Stock Options
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	50,000	50,000	-		0	Class A Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	50,000	50,000	-		0	Class A Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	50,000	6,539,604	-		-	Class B Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	50,000	6,489,604	-		-	Class B Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	50,000	6,439,604	-		-	Class B Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	50,000	50,000	-		0	Class A Common Stock
Omega Healthcare Investors Inc	Gail D. Makode	CHIEF LEGAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	48,169	125,473	-		-	Profits Interest Units
Omega Healthcare Investors Inc	Matthew Gourmand	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	48,169	125,473	-		-	Profits Interest Units
Omega Healthcare Investors Inc	Vikas Gupta	Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	48,169	125,473	-		-	Profits Interest Units
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	48,000	78,225	-		-	Stock Option
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.66 per share.	10 Jan 2025	48,000	414,680 (1%)	0%	37.7	1,807,680	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 67.40 per share.	10 Jan 2025	48,000	366,680 (1%)	0%	67.4	3,235,344	Common Stock
Omega Healthcare Investors Inc	Gail D. Makode	CHIEF LEGAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	46,508	77,304	-		-	Profits Interest Units
Omega Healthcare Investors Inc	Matthew Gourmand	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	46,508	77,304	-		-	Profits Interest Units
Omega Healthcare Investors Inc	Vikas Gupta	Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	46,508	77,304	-		-	Profits Interest Units
Alexandria Real Estate Equities Inc	Joel S. Marcus	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	46,207	456,144 (0%)	0%		0	Common Stock
RF Ind Ltd	Robert D. Dawson	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	43,750	304,028 (3%)	0%		0	Common Stock
Blackstone	Jonathan D. Gray	Director, President & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	41,801	3,122,918 (0%)	0%		0	Common Stock
Blackstone	Joseph Patrick Baratta	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	41,801	841,550 (0%)	0%		0	Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 168.29 per share.	10 Jan 2025	41,288	6,312	-	168.3	6,948,234	Class A Common Stock
Fortrea Holdings Inc	Thomas H. Pike	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	40,220	171,136	-		0	Common Stock
Fortrea Holdings Inc	Thomas H. Pike	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	40,220	291,611	-		-	Restricted Stock Unit
Verastem Inc	Daniel Calkins	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	38,800	86,439 (0%)	0%		0	Common Stock
Omega Healthcare Investors Inc	Neal A. Ballew	CHIEF ACCOUNTING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	38,318	106,107	-		-	Profits Interest Units
Praxis Precision Medicines Inc	Marcio Souza	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	37,500	53,960	-		0	Common Stock
BioAffinity Tech Inc	Maria Zannes	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	37,037	280,359	-		0	Common Stock
Omega Healthcare Investors Inc	Neal A. Ballew	CHIEF ACCOUNTING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	36,993	67,789	-		-	Profits Interest Units
Genpact Ltd	Balkrishan Kalra	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share.	10 Jan 2025	36,461	230,943 (0%)	0%	43.3	1,580,220	Common Shares
Mobile infra Corp	Jeffrey B. Osher	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	36,192	0	-		-	Restricted Stock Units
Mobile infra Corp	Jeffrey B. Osher	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	36,192	131,192	-		-	Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 170.24 per share.	10 Jan 2025	35,967	1,800	-	170.2	6,123,094	Class A Common Stock
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	34,750	2,320	-		-	Employee Stock Option (Right to Buy)
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share.	10 Jan 2025	34,750	275,780 (0%)	0%	9.5	328,388	Common Stock
Pacific Biosciences of California Inc	Oene Mark Van	See Remarks	Sale of securities on an exchange or to another person at price $ 2.03 per share.	10 Jan 2025	34,405	1,597,454 (1%)	0%	2.0	69,980	Common Stock
Blackstone	Michael S. Chae	CFO & Vice Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	33,604	873,683 (0%)	0%		0	Common Stock
Mobile infra Corp	Damon Jones	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	33,334	0	-		-	Restricted Stock Units
Mobile infra Corp	Damon Jones	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	33,334	33,334	-		-	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.94 per share.	10 Jan 2025	32,957	399,637 (1%)	0%	18.9	624,206	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.46 per share.	10 Jan 2025	32,957	366,680 (1%)	0%	66.5	2,190,477	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	32,957	14,667	-		-	Stock Option
Mobile infra Corp	David M. Garfinkle	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	31,587	46,287	-		-	Common Stock
Mobile infra Corp	David M. Garfinkle	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	31,587	0	-		-	Restricted Stock Units
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 169.14 per share.	10 Jan 2025	31,410	10,429	-	169.1	5,312,719	Class A Common Stock
Urban Outfitters Inc	Harry S. Cherken	Director	Sale of securities on an exchange or to another person at price $ 57.10 per share.	10 Jan 2025	31,305	533,991 (0%)	0%	57.1	1,787,516	Common Shares
RF Ind Ltd	Peter Yin	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	31,250	31,250	-		-	Stock Option (Right to Buy)
RF Ind Ltd	Ray Bibisi	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	31,250	31,250	-		-	Stock Option (Right to Buy)
Eledon Pharma Inc	John S. McBride	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	30,870	30,870	-		-	Stock Option (right to buy)
Eledon Pharma Inc	June Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	30,870	30,870	-		-	Stock Option (right to buy)
Eledon Pharma Inc	Jan L. Hillson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	30,870	30,870	-		-	Stock Option (right to buy)
Eledon Pharma Inc	Allan Douglas Kirk	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	30,870	30,870	-		-	Stock Option (right to buy)
Central Plains Bancshares Inc	Kurt A. Haecker	EVP and CLO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	30,000	30,000	-		-	Stock Options
Central Plains Bancshares Inc	Lisa A. Harris	EVP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	30,000	30,000	-		-	Stock Options
Box Inc (Class A)	Dylan C. Smith	Chief Financial Officer	Gift of securities by or to the insider at price $ 0.00 per share.	10 Jan 2025	30,000	1,479,684 (0%)	0%		0	Class A Common Stock
Cellectar Biosciences Inc	Jarrod Longcor	Chief Operating Officer	Purchase of securities on an exchange or from another person at price $ 0.28 per share.	10 Jan 2025	30,000	83,141 (0%)	0%	0.3	8,400	Common Stock
Mobile infra Corp	Danica Holley	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	29,168	44,651	-		-	Common Stock
Mobile infra Corp	Danica Holley	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	29,168	0	-		-	Restricted Stock Units
Mobile infra Corp	Stephanie Hogue	Director, President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.94 per share.	10 Jan 2025	28,891	49,234	-	3.9	113,831	Common Stock
Collegium pharma Inc	Shirley R. Kuhlmann	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.34 per share.	10 Jan 2025	27,500	146,684 (0%)	0%	21.3	586,850	Common Stock
Collegium pharma Inc	Shirley R. Kuhlmann	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	27,500	0	-		-	Stock Option (Right to Purchase)
Eledon Pharma Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	27,000	27,000	-		-	Restricted Stock Units
Central Plains Bancshares Inc	Steven D. Kunzman	Director, President & CEO, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	25,000	40,000	-		0	Common Stock
Roku Inc (Class A)	Anthony Wood	Director, CEO and Chairman BOD, Ten Percent Owner		10 Jan 2025	25,000	17,003,111	-		-	Class B Common Stock
Roku Inc (Class A)	Anthony Wood	Director, CEO and Chairman BOD, Ten Percent Owner		10 Jan 2025	25,000	51,538 (0%)	0%		-	Class A Common Stock
Roku Inc (Class A)	Anthony Wood	Director, CEO and Chairman BOD, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 79.77 per share.	10 Jan 2025	25,000	26,538 (0%)	0%	79.8	1,994,250	Class A Common Stock
Praxis Precision Medicines Inc	Timothy E. Kelly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	25,000	25,000	-		-	Stock Option (Right to Buy)
Verastem Inc	Daniel Paterson	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	25,000	356,149 (0%)	0%		0	Common Stock
Blackstone	Vikrant Sawhney	Chief Administrative Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	24,042	753,909 (0%)	0%		0	Common Stock
Urban Outfitters Inc	Harry S. Cherken	Director	Sale of securities on an exchange or to another person at price $ 57.59 per share.	10 Jan 2025	23,695	510,296 (0%)	0%	57.6	1,364,595	Common Shares
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 72.51 per share.	10 Jan 2025	23,434	272,120	-	72.5	1,699,199	Ordinary Shares
Meta Capex	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner		10 Jan 2025	22,946	193,550,828	-		-	Class B Common Stock
Meta Capex	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner		10 Jan 2025	22,946	22,946 (0%)	0%		0	Class A Common Stock
Praxis Precision Medicines Inc	Alex Nemiroff	General Counsel and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	22,500	22,500	-		-	Stock Option (Right to Buy)
Genpact Ltd	Anil Nanduru	Senior Vice President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share.	10 Jan 2025	22,215	102,661 (0%)	0%	43.3	962,798	Common Shares
Transocean Ltd	James Roderick Mackenzie	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 4.05 per share.	10 Jan 2025	22,000	229,596 (0%)	0%	4.1	89,100	Registered Shares
BioAffinity Tech Inc	Xavier Trinidad Reveles	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	21,604	41,943	-		0	Common Stock
Collegium pharma Inc	Shirley R. Kuhlmann	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 32.87 per share.	10 Jan 2025	21,400	125,284 (0%)	0%	32.9	703,407	Common Stock
Genpact Ltd	Riju Vashisht	Senior Vice President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share.	10 Jan 2025	20,298	132,453 (0%)	0%	43.3	879,715	Common Shares
Central Plains Bancshares Inc	Bradley M. Kool	1st VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	20,000	20,000	-		-	Stock Options
Central Plains Bancshares Inc	Kenneth W. Wiemers	EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	20,000	20,000	-		-	Stock Options
Copart	Diane M. Morefield	Director	Gift of securities by or to the insider at price $ 0.00 per share.	10 Jan 2025	20,000	20,000 (0%)	0%		0	Common Stock
Copart	Diane M. Morefield	Director	Gift of securities by or to the insider at price $ 0.00 per share.	10 Jan 2025	20,000	0 (0%)	0%		0	Common Stock
Jabil	Steven A. Raymund	Director	Sale of securities on an exchange or to another person at price $ 151.30 per share.	10 Jan 2025	20,000	119,108 (0%)	0%	151.3	3,026,000	Common Stock
Genpact Ltd	Michael Weiner	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share.	10 Jan 2025	19,540	146,561 (0%)	0%	43.3	846,864	Common Shares
SELLAS Life Sciences Grp Inc	Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
SELLAS Life Sciences Grp Inc	David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
SELLAS Life Sciences Grp Inc	John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
SELLAS Life Sciences Grp Inc	Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
SELLAS Life Sciences Grp Inc	Katherine Bach Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
iBio Inc	David A. Arkowitz	Director	Purchase of securities on an exchange or from another person at price $ 2.72 per share.	10 Jan 2025	18,382	18,382 (0%)	0%	2.7	49,999	Common Stock
CorMedix Inc	Joseph Todisco	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share.	10 Jan 2025	17,829	308,028 (1%)	0%	11.2	199,507	Common Stock
Central Plains Bancshares Inc	Kurt A. Haecker	EVP and CLO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	17,500	28,000	-		0	Common Stock
Central Plains Bancshares Inc	Lisa A. Harris	EVP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	17,500	19,750	-		0	Common Stock
Mobile infra Corp	Brad Greiwe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	17,381	17,381	-		-	Common Stock
Mobile infra Corp	Brad Greiwe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	17,381	0	-		-	Restricted Stock Units
Comstock Holding Co. Inc (Class A)	Christopher Guthrie	Chief Financial Officer & EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	16,741	16,741	-		-	Restricted Stock Units (RSUs)
Comstock Holding Co. Inc (Class A)	Christopher Guthrie	Chief Financial Officer & EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	16,741	124,364 (1%)	0%		0	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Timothy J. Steffan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	16,741	111,962 (1%)	0%		0	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Timothy J. Steffan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	16,741	16,741	-		-	Restricted Stock Units (RSUs)
RF Ind Ltd	Peter Yin	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	15,625	119,140 (1%)	0%		0	Common Stock
RF Ind Ltd	Ray Bibisi	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	15,625	52,501 (0%)	0%		0	Common Stock
CarPartscom Inc	David Meniane	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	15,069	1,506,919 (4%)	0%		0	Common Stock
CarPartscom Inc	David Meniane	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	15,069	0	-		-	Restricted Stock Units
BioAffinity Tech Inc	Steven Girgenti	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	14,814	1,080,062	-		0	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	14,667	0	-		-	Stock Option
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.94 per share.	10 Jan 2025	14,667	381,347 (1%)	0%	18.9	277,793	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.05 per share.	10 Jan 2025	14,667	366,680 (1%)	0%	66.1	968,798	Common Stock
Genpact Ltd	Sameer Dewan	Senior Vice President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share.	10 Jan 2025	13,377	98,467 (0%)	0%	43.3	579,759	Common Shares
Atlas Lithium Corp	Igor Tkachenko	VP, Corporate Strategy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	13,275	192,530	-		0	Common Stock
Genpact Ltd	Heather D. White	SVP & Chief Legal Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share.	10 Jan 2025	13,221	47,122 (0%)	0%	43.3	572,998	Common Shares
Box Inc (Class A)	Dylan C. Smith	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 31.05 per share.	10 Jan 2025	13,000	1,466,684 (0%)	0%	31.1	403,650	Class A Common Stock
Globus Medical Inc (Class A)	Keith W. Pfeil	COO, CFO	Sale of securities on an exchange or to another person at price $ 88.17 per share.	10 Jan 2025	12,501	1,666 (0%)	0%	88.2	1,102,213	Class A Common Stock
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share.	10 Jan 2025	12,500	253,530 (0%)	0%	9.5	118,125	Common Stock
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	12,500	37,070	-		-	Employee Stock Option (Right to Buy)
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Sale of securities on an exchange or to another person at price $ 28.53 per share.	10 Jan 2025	12,500	241,030 (0%)	0%	28.5	356,625	Common Stock
Praxis Precision Medicines Inc	Timothy E. Kelly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	24,706	-		0	Common Stock
SELLAS Life Sciences Grp Inc	Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	22,900 (0%)	0%		0	Common Stock
SELLAS Life Sciences Grp Inc	David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	23,082 (0%)	0%		0	Common Stock
SELLAS Life Sciences Grp Inc	John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	22,900 (0%)	0%		0	Common Stock
SELLAS Life Sciences Grp Inc	Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	22,900 (0%)	0%		0	Common Stock
SELLAS Life Sciences Grp Inc	Katherine Bach Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	21,000 (0%)	0%		0	Common Stock
Blackstone	John Finley G.	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,388	399,525 (0%)	0%		0	Common Stock
Sera Prognostics Inc (Class A)	Robert G. Harrison	Chief Information Officer	Sale of securities on an exchange or to another person at price $ 7.30 per share.	10 Jan 2025	12,372	118,674	-	7.3	90,316	Class A Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	12,307	496	-		-	Stock Option
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.26 per share.	10 Jan 2025	12,307	378,987 (1%)	0%	35.3	433,945	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.83 per share.	10 Jan 2025	12,307	366,680 (1%)	0%	66.8	822,490	Common Stock
Sera Prognostics Inc (Class A)	Paul Kearney	Chief Data Officer	Sale of securities on an exchange or to another person at price $ 7.36 per share.	10 Jan 2025	12,275	164,614	-	7.4	90,344	Class A Common Stock
Comtech Telecom Corp	Jeffery Paul Robertson	President, T&W Segment	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,107	143,559	-		-	Restricted Stock Units
Sera Prognostics Inc (Class A)	Benjamin G. Jackson	General Counsel	Sale of securities on an exchange or to another person at price $ 7.36 per share.	10 Jan 2025	12,041	129,704	-	7.4	88,622	Class A Common Stock
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	12,000	0	-		-	Stock Options (Right to Buy)
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share.	10 Jan 2025	12,000	70,838 (0%)	0%	2.1	25,680	Class A Common Stock, $0.01 par value
Genpact Ltd	Piyush Mehta	Senior Vice President and CHRO	Sale of securities on an exchange or to another person at price $ 42.83 per share.	10 Jan 2025	12,000	151,182 (0%)	0%	42.8	513,960	Common Shares
Treace Medical Concepts Inc	John Treace	Director, Chief Executive Officer, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	10 Jan 2025	11,905	6,511,190	-		0	Common Stock
RE/MAX Holdings Inc (Class A) Board Meeting	Adam K. Peterson	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 9.64 per share.	10 Jan 2025	11,798	3,247,929 (18%)	0%	9.6	113,733	Common Stock
Akari Therapeutics PLC (ADR)	Abizer Gaslightwala	Director	Grant, award, or other acquisition of securities at price $ 1.22 per share.	10 Jan 2025	11,640	47,500 (0%)	0%	1.2	14,201	American Depository Shares representing Ordinary Shares
Akari Therapeutics PLC (ADR)	Abizer Gaslightwala	Director	Grant, award, or other acquisition of securities at price $ 1.22 per share.	10 Jan 2025	11,439	35,860 (0%)	0%	1.2	13,956	American Depository Shares representing Ordinary Shares
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.40 per share.	10 Jan 2025	11,359	355,321 (1%)	0%	66.4	754,260	Common Stock
Fortrea Holdings Inc	Thomas H. Pike	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 18.04 per share.	10 Jan 2025	11,268	159,868	-	18.0	203,275	Common Stock
Praxis Precision Medicines Inc	Alex Nemiroff	General Counsel and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	11,250	21,461	-		0	Common Stock
National Research Corp	Michael D. Hays	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	11,021	11,021	-		-	Employee Stock Option (right to buy)
Orthofix Medical Inc	Massimo Calafiore	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 16.83 per share.	10 Jan 2025	10,078	133,354 (0%)	0%	16.8	169,619	Common Stock
Kymera Therapeutics Inc	Nello Mainolfi	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share.	10 Jan 2025	10,000	659,959	-	2.1	20,800	Common Stock
Kymera Therapeutics Inc	Nello Mainolfi	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	10,000	495,559	-		-	Stock Option (Right to Buy)
Kymera Therapeutics Inc	Bruce Jacobs	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share.	10 Jan 2025	10,000	178,921	-	2.1	20,800	Common Stock
Kymera Therapeutics Inc	Bruce Jacobs	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	10,000	94,899	-		-	Stock Option (Right to Buy)
DocuSign Inc	Peter Solvik	Director	Sale of securities on an exchange or to another person at price $ 91.26 per share.	10 Jan 2025	10,000	150,253 (0%)	0%	91.3	912,600	Common Stock
Atlas Energy Soln Inc (Class A)	Stacy Hock	Director, Ten Percent Owner, Member of 10% Owner Group		10 Jan 2025	10,000	907,604	-	22.0	219,600	Common Stock
Argan Inc	Peter W. Getsinger	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	10,000	54,500	-		-	Option to Purchase Common Stock
DocuSign Inc	Enrique T. Salem	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.43 per share.	10 Jan 2025	10,000	172,265 (0%)	0%	13.4	134,300	Common Stock
DocuSign Inc	Enrique T. Salem	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	10,000	0	-		-	Option (Right to Buy)
DocuSign Inc	Enrique T. Salem	Director	Sale of securities on an exchange or to another person at price $ 91.56 per share.	10 Jan 2025	10,000	162,265 (0%)	0%	91.6	915,610	Common Stock
Praxis Precision Medicines Inc	Lauren Mastrocola	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	10,000	10,000	-		-	Stock Option (Right to Buy)
Workiva Inc (Class A)	Martin J. Vanderploeg	Director	Gift of securities by or to the insider at price $ 0.00 per share.	10 Jan 2025	9,806	314,985 (0%)	0%		0	Class A Common Stock
Workiva Inc (Class A)	Martin J. Vanderploeg	Director	Gift of securities by or to the insider at price $ 0.00 per share.	10 Jan 2025	9,806	355,675 (0%)	0%		0	Class A Common Stock
Freshworks Inc (Class A)	Jennifer Taylor	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	9,370	164,080	-		-	Class B Common Stock
Freshworks Inc (Class A)	Jennifer Taylor	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	9,370	75,000	-		-	Restricted Stock Units
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 169.35 per share.	10 Jan 2025	9,333	37,767	-	169.3	1,580,506	Class A Common Stock
Orthofix Medical Inc	Massimo Calafiore	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 17.14 per share.	10 Jan 2025	9,203	124,151 (0%)	0%	17.1	157,757	Common Stock
iBio Inc	Gary L. Sender	Director	Purchase of securities on an exchange or from another person at price $ 2.72 per share.	10 Jan 2025	9,191	9,191 (0%)	0%	2.7	25,000	Common Stock
iBio Inc	Martin B. Brenner	Director, See Remarks	Purchase of securities on an exchange or from another person at price $ 2.72 per share.	10 Jan 2025	9,191	18,316 (0%)	0%	2.7	25,000	Common Stock
iBio Inc	Felipe Duran	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 2.72 per share.	10 Jan 2025	9,191	11,139 (0%)	0%	2.7	25,000	Common Stock
iBio Inc	Marc Banjak	Chief Legal Officer	Purchase of securities on an exchange or from another person at price $ 2.72 per share.	10 Jan 2025	9,191	11,066 (0%)	0%	2.7	25,000	Common Stock
Central Plains Bancshares Inc	Bradley M. Kool	1st VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	9,000	10,200	-		0	Common Stock
Central Plains Bancshares Inc	Kenneth W. Wiemers	EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	9,000	10,000	-		0	Common Stock
Cartesian Therapeutics Inc	Christopher M. Jewell	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share.	10 Jan 2025	9,000	62,490 (0%)	0%	3.2	29,070	Common Stock
Cartesian Therapeutics Inc	Christopher M. Jewell	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	9,000	67,432	-		-	Stock Option (Right to Buy)
Newmont	Natascha Viljoen	EVP & COO	Sale of securities on an exchange or to another person at price $ 40.00 per share.	10 Jan 2025	9,000	145,967 (0%)	0%	40	360,000	Common Stock, $1.60 par value
Hagerty Inc (Class A)	Robert I. Kauffman	Director	Sale of securities on an exchange or to another person at price $ 9.32 per share.	10 Jan 2025	8,918	4,389,521	-	9.3	83,116	Class A Common Stock
JFrog Ltd	Yoav Landman	Director, CHIEF TECHNOLOGY OFFICER	Sale of securities on an exchange or to another person at price $ 31.33 per share.	10 Jan 2025	8,901	6,573,341	-	31.3	278,868	Ordinary Shares
Fate Therapeutics Inc	Bahram Valamehr	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 1.54 per share.	10 Jan 2025	8,705	349,364 (0%)	0%	1.5	13,406	Common Stock
AAR Corp Results Board Meeting	John M. Holmes	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 65.84 per share.	10 Jan 2025	8,641	346,680 (0%)	0%	65.8	568,896	Common Stock
BioAffinity Tech Inc	Timothy P. Zannes	Secretary, EVP, Gen. Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	8,641	54,765	-		0	Common Stock
Treace Medical Concepts Inc	Mark L. Hair	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	10 Jan 2025	8,594	359,321	-		0	Common Stock
Eledon Pharma Inc	Keith A. Katkin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	8,575	8,575	-		-	Restricted Stock Units
Verastem Inc	Daniel Paterson	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 5.24 per share.	10 Jan 2025	8,568	347,581 (0%)	0%	5.2	44,896	Common Stock
Sera Prognostics Inc (Class A)	Benjamin G. Jackson	General Counsel	Sale of securities on an exchange or to another person at price $ 6.20 per share.	10 Jan 2025	8,407	112,154	-	6.2	52,123	Class A Common Stock
Globus Medical Inc (Class A)	Keith W. Pfeil	COO, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.27 per share.	10 Jan 2025	8,334	14,167 (0%)	0%	53.3	443,952	Class A Common Stock
Globus Medical Inc (Class A)	Keith W. Pfeil	COO, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	8,334	833	-		-	Stock Option (Right to Buy Class A Common Stock)
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 168.19 per share.	10 Jan 2025	8,161	41,839	-	168.2	1,372,566	Class A Common Stock
Atlassian Corp (Class A)	Michael Cannon-Brookes	Director, CEO, Co-Founder, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 243.10 per share.	10 Jan 2025	8,126	432,349 (0%)	0%	243.1	1,975,403	Class A Common Stock
Atlassian Corp (Class A)	Scott Farquhar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 243.10 per share.	10 Jan 2025	8,126	434,142 (0%)	0%	243.1	1,975,404	Class A Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	8,000	80,326 (0%)	0%	18.9	151,520	Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	8,000	72,326 (0%)	0%	66.3	530,646	Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	8,000	47,870	-		-	Stock Option
eHealth Inc	Francis S. Soistman	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share.	10 Jan 2025	7,930	813,946 (3%)	0%	9.9	78,111	Common Stock
Sera Prognostics Inc (Class A)	Benjamin G. Jackson	General Counsel	Sale of securities on an exchange or to another person at price $ 6.38 per share.	10 Jan 2025	7,912	120,561	-	6.4	50,479	Class A Common Stock
Gabelli Global Small and Mid Cap Value Trust	Mario J. Gabelli	Director, Ten Percent Owner, Control Person of Adviser	Purchase of securities on an exchange or from another person at price $ 11.67 per share.	10 Jan 2025	7,700	39,286 (0%)	0%	11.7	89,857	Common Shares, Par Value $0.001
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 169.96 per share.	10 Jan 2025	7,603	2,826	-	170.0	1,292,175	Class A Common Stock
Argan Inc	Peter W. Getsinger	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.19 per share.	10 Jan 2025	7,385	19,977 (0%)	0%	41.2	304,188	Common Stock
Argan Inc	Peter W. Getsinger	Director	Sale of securities on an exchange or to another person at price $ 165.29 per share.	10 Jan 2025	7,385	11,792 (0%)	0%	165.3	1,220,667	Common Stock
Climb Global Soln Inc	Andrew E. Clark	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	7,356	37,840 (0%)	0%		0	Common Stock
Hims & Hers Health Inc (Class A)	Michael Chi	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 24.07 per share.	10 Jan 2025	7,259	193,601	-	24.1	174,724	Class A Common Stock
Hims & Hers Health Inc (Class A)	Michael Chi	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.82 per share.	10 Jan 2025	7,259	200,860	-	6.8	49,506	Class A Common Stock
Hims & Hers Health Inc (Class A)	Michael Chi	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	7,259	137,921	-		-	Stock Option (right to buy)
Comstock Holding Co. Inc (Class A)	Christopher Guthrie	Chief Financial Officer & EVP	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.10 per share.	10 Jan 2025	7,216	117,148 (1%)	0%	8.1	58,450	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Timothy J. Steffan	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.10 per share.	10 Jan 2025	7,216	104,746 (1%)	0%	8.1	58,450	Class A Common Stock, $0.01 par value
Hagerty Inc (Class A)	Robert I. Kauffman	Director	Sale of securities on an exchange or to another person at price $ 9.35 per share.	10 Jan 2025	7,061	4,398,439	-	9.3	66,020	Class A Common Stock
Shattuck Labs Inc	Arundathy Nirmalini Pandite	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share.	10 Jan 2025	6,884	209,476	-	1.2	8,192	Common Stock
CBL& Associates Properties Inc - Ordinary Shares - New	Andrew F. Cobb	Exec VP-Accounting	Sale of securities on an exchange or to another person at price $ 28.84 per share.	10 Jan 2025	6,800	37,247	-	28.8	196,137	Common Stock
CorMedix Inc	Matthew T. David	Chief Financial Officer		10 Jan 2025	6,515	95,270 (0%)	0%	11.2	72,903	Common Stock
AAR Corp Results Board Meeting	Eric S. Pachapa	VP-CAO & Controller	Sale of securities on an exchange or to another person at price $ 66.93 per share.	10 Jan 2025	6,500	24,342 (0%)	0%	66.9	435,053	Common Stock
Freshworks Inc (Class A)	Roxanne S. Austin	Director	Sale of securities on an exchange or to another person at price $ 15.69 per share.	10 Jan 2025	6,303	193,793	-	15.7	98,894	Class A Common Stock
Gabelli Global Small and Mid Cap Value Trust	Mario J. Gabelli	Director, Ten Percent Owner, Control Person of Adviser	Purchase of securities on an exchange or from another person at price $ 11.66 per share.	10 Jan 2025	6,300	45,586 (0%)	0%	11.7	73,472	Common Shares, Par Value $0.001
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 6.39 per share.	10 Jan 2025	6,287	4,827	-	6.4	40,174	Class A Common Stock
CarPartscom Inc	David Meniane	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share.	10 Jan 2025	6,191	1,500,728 (4%)	0%	1.1	6,996	Common Stock
BioAffinity Tech Inc	J. Michael Edwards	VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	6,172	120,128	-		0	Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 168.85 per share.	10 Jan 2025	6,112	200	-	168.8	1,031,999	Class A Common Stock
Collegium pharma Inc	Shirley R. Kuhlmann	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 33.64 per share.	10 Jan 2025	6,100	119,184 (0%)	0%	33.6	205,220	Common Stock
JFrog Ltd	Yoav Landman	Director, CHIEF TECHNOLOGY OFFICER	Sale of securities on an exchange or to another person at price $ 31.87 per share.	10 Jan 2025	6,099	6,567,242	-	31.9	194,375	Ordinary Shares
Lifeway Foods Inc	Julie Smolyansky	Director, CEO, President and Secretary, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	6,070	12,138	-		-	Restricted Stock Units
Lifeway Foods Inc	Julie Smolyansky	Director, CEO, President and Secretary, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	6,070	2,115,933 (13%)	0%		0	Common Stock, no par value
Fate Therapeutics Inc	Jerome Charles Bressi	See Remarks	Sale of securities on an exchange or to another person at price $ 1.55 per share.	10 Jan 2025	5,980	270,203 (0%)	0%	1.6	9,269	Common Stock
Twist Bioscience Corp	Adam Laponis	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 43.26 per share.	10 Jan 2025	5,886	110,096 (0%)	0%	43.3	254,646	Common Stock
fuboTV Inc	Alberto Horihuela Suarez	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 5.98 per share.	10 Jan 2025	5,868	1,446,730	-	6.0	35,091	Common Stock
Globus Medical Inc (Class A)	Keith W. Pfeil	COO, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.65 per share.	10 Jan 2025	5,833	5,833 (0%)	0%	49.6	289,608	Class A Common Stock
Globus Medical Inc (Class A)	Keith W. Pfeil	COO, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	5,833	0	-		-	Stock Option (Right to Buy Class A Common Stock)
CorMedix Inc	Elizabeth Hurlburt	EVP	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share.	10 Jan 2025	5,790	115,728 (0%)	0%	11.2	64,790	Common Stock
Shattuck Labs Inc	Casi DeYoung	Chief Business Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share.	10 Jan 2025	5,727	83,762	-	1.2	6,815	Common Stock
CorMedix Inc	Erin Mistry	EVP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share.	10 Jan 2025	5,689	100,992 (0%)	0%	11.2	63,660	Common Stock
Fate Therapeutics Inc	Cindy Tahl R.	See Remarks	Sale of securities on an exchange or to another person at price $ 1.55 per share.	10 Jan 2025	5,654	336,707 (0%)	0%	1.6	8,764	Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	5,385	72,326 (0%)	0%	66.3	357,191	Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	5,385	77,711 (0%)	0%	37.7	202,799	Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	5,385	0	-		-	Stock Option
ABM Ind Inc	Scott B. Salmirs	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.42 per share.	10 Jan 2025	5,318	418,024 (0%)	0%	50.4	268,134	Common Stock
RF Ind Ltd	Robert D. Dawson	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.83 per share.	10 Jan 2025	5,156	260,278 (2%)	0%	3.8	19,760	Common Stock
United Therapeutics Corp	Christopher Patusky	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	5,000	5,000	-		-	Stock Option
United Therapeutics Corp	Christopher Patusky	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share.	10 Jan 2025	5,000	5,900 (0%)	0%	175.4	877,150	Common Stock
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner		10 Jan 2025	5,000	0	-		-	Warrants (Right to Buy)
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner		10 Jan 2025	5,000	75,838 (0%)	0%	8.2	40,900	Class A Common Stock, $0.01 par value
Praxis Precision Medicines Inc	Lauren Mastrocola	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	5,000	10,871	-		0	Common Stock
Keysight Tech	Ronald S. Nersesian	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.25 per share.	10 Jan 2025	4,899	231,906 (0%)	0%	162.3	794,871	Common Stock
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 7.18 per share.	10 Jan 2025	4,896	12,788	-	7.2	35,153	Class A Common Stock
Shattuck Labs Inc	Abhinav A. Shukla	Chief Technical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share.	10 Jan 2025	4,830	74,597	-	1.2	5,748	Common Stock
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 6.29 per share.	10 Jan 2025	4,827	0	-	6.3	30,362	Class A Common Stock
Treace Medical Concepts Inc	Sean F. Scanlan	Chief Innovation Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	10 Jan 2025	4,821	225,253	-		0	Common Stock
Treace Medical Concepts Inc	Aaron J. Berutti	SVP, Sales		10 Jan 2025	4,821	160,970	-		0	Common Stock
Box Inc (Class A)	Eli Berkovitch	VP Chief Acct Ofr & Controller	Sale of securities on an exchange or to another person at price $ 31.06 per share.	10 Jan 2025	4,791	132,741 (0%)	0%	31.1	148,808	Class A Common Stock
Agenus Inc	Garo H. Armen	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 3.12 per share.	10 Jan 2025	4,777	129,148 (0%)	0%	3.1	14,904	Common Stock
Energy Vault Holdings Inc	Akshay Ladwa	Chief Engineering Officer	Sale of securities on an exchange or to another person at price $ 1.96 per share.	10 Jan 2025	4,762	1,457,602	-	2.0	9,318	Common Stock
Freshworks Inc (Class A)	Jennifer Taylor	Director	Sale of securities on an exchange or to another person at price $ 15.49 per share.	10 Jan 2025	4,685	37,286	-	15.5	72,571	Class A Common Stock
Freshworks Inc (Class A)	Jennifer Taylor	Director		10 Jan 2025	4,685	41,971	-		0	Class A Common Stock
Freshworks Inc (Class A)	Jennifer Taylor	Director		10 Jan 2025	4,685	159,395	-		-	Class B Common Stock
Treace Medical Concepts Inc	Scot Michael Elder	Chief Legl & Comp Off, CorpSec	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	10 Jan 2025	4,544	445,134	-		0	Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 71.44 per share.	10 Jan 2025	4,446	295,554	-	71.4	317,616	Ordinary Shares
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 8.18 per share.	10 Jan 2025	4,443	71,395 (0%)	0%	8.2	36,344	Class A Common Stock, $0.01 par value
Littelfuse Inc	Chad Marak	SVP & GM Semiconductor Busines	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	4,253	10,328 (0%)	0%		0	Common Stock
Littelfuse Inc	Sung-Jip Peter Kim	SVP & GM Industrial Business	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	4,253	8,322 (0%)	0%		0	Common Stock
Lamb Weston	Eryk J. Spytek	Gen Counsel & Chief Compl Off	Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.73 per share.	10 Jan 2025	4,249	30,213 (0%)	0%	60.7	258,042	Common Stock
Xos Inc	Dakota Semler	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.45 per share.	10 Jan 2025	4,122	513,634	-	3.5	14,221	Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	4,000	76,326 (0%)	0%	37.7	150,960	Common Stock
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	4,000	7,970	-		-	Stock Option
AAR Corp Results Board Meeting	Sean M. Gillen	Senior VP-CFO		10 Jan 2025	4,000	72,326 (0%)	0%	66.3	265,323	Common Stock
Hagerty Inc (Class A)	Robert I. Kauffman	Director	Sale of securities on an exchange or to another person at price $ 9.45 per share.	10 Jan 2025	3,972	4,385,549	-	9.4	37,535	Class A Common Stock
Leggett & Platt Inc	Joseph W. Mcclanathan	Director	Grant, award, or other acquisition of securities at price $ 7.75 per share.	10 Jan 2025	3,966	74,043 (0%)	0%	7.8	30,750	Common Stock
Willamette Valley Vineyard Inc	Sarah Rose	Director	Purchase of securities on an exchange or from another person at price $ 3.71 per share.	10 Jan 2025	3,893	5,000 (0%)	0%	3.7	14,439	Common Stock
Xos Inc	Giordano Sordoni	Director, Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.45 per share.	10 Jan 2025	3,806	1,166,956	-	3.5	13,131	Common Stock
Leggett & Platt Inc	Manuel A. Fernandez	Director	Grant, award, or other acquisition of securities at price $ 7.75 per share.	10 Jan 2025	3,708	71,492 (0%)	0%	7.8	28,750	Common Stock
Pro-Dex Inc (co)	Raymond E. Cabillot	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 46.66 per share.	10 Jan 2025	3,624	356,022 (9%)	0%	46.7	169,096	Common Stock
Credo Tech Grp Holding Ltd	Daniel Fleming	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 72.59 per share.	10 Jan 2025	3,590	638,764	-	72.6	260,581	Ordinary Shares
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 74.13 per share.	10 Jan 2025	3,476	200,000	-	74.1	257,677	Ordinary Shares
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 6.39 per share.	10 Jan 2025	3,458	2,695	-	6.4	22,097	Class A Common Stock
Eledon Pharma Inc	John S. McBride	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	3,430	3,430	-		-	Restricted Stock Units
Eledon Pharma Inc	June Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	3,430	3,430	-		-	Restricted Stock Units
Eledon Pharma Inc	Jan L. Hillson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	3,430	3,430	-		-	Restricted Stock Units
Eledon Pharma Inc	Allan Douglas Kirk	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	3,430	3,430	-		-	Restricted Stock Units
ESAB Corp	Vusa Mlingo	SVP, Strategy & Business Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	3,255	10,132	-		-	Common stock, par value $0.001
ESAB Corp	Vusa Mlingo	SVP, Strategy & Business Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	3,255	0	-		-	Restricted Stock Units
Atlassian Corp (Class A)	Michael Cannon-Brookes	Director, CEO, Co-Founder, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 244.05 per share.	10 Jan 2025	3,157	429,192 (0%)	0%	244.0	770,453	Class A Common Stock
Atlassian Corp (Class A)	Scott Farquhar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 244.05 per share.	10 Jan 2025	3,156	430,986 (0%)	0%	244.0	770,209	Class A Common Stock
Life360 Inc	Russell Burke	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 42.74 per share.	10 Jan 2025	3,104	151,858	-	42.7	132,665	Common stock
American Coastal Insurance Corp	Bennett Bradford Martz	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	3,050	75,344	-		-	Restricted Stock Units
Eagle Bancorp Inc (MD)	A. Leslie Ludwig	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	3,000	36,413 (0%)	0%		0	Common Stock
Eagle Bancorp Inc (MD)	A. Leslie Ludwig	Director	Other type of transaction at price $ 0.00 per share.	10 Jan 2025	3,000	5,000 (0%)	0%		0	Common Stock
Newmont	Peter Toth	EVP & CDO	Sale of securities on an exchange or to another person at price $ 40.00 per share.	10 Jan 2025	3,000	82,596 (0%)	0%	40	120,000	Common Stock, $1.60 par value
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 168.47 per share.	10 Jan 2025	2,900	47,100	-	168.5	488,563	Class A Common Stock
Dycom Ind Inc	Peter T. Pruitt	Director	Sale of securities on an exchange or to another person at price $ 175.08 per share.	10 Jan 2025	2,900	14,533 (0%)	0%	175.1	507,732	Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 170.83 per share.	10 Jan 2025	2,826	0	-	170.8	482,768	Class A Common Stock
Fidelity National Fin Inc	Halim Dhanidina	Director	Sale of securities on an exchange or to another person at price $ 54.85 per share.	10 Jan 2025	2,800	16,716 (0%)	0%	54.9	153,580	Common Stock
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,730	78,605 (1%)	0%		0	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,730	5,458	-		-	Restricted Stock Units (RSUs)
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,724	81,329 (1%)	0%		0	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,724	8,171	-		-	Restricted Stock Units (RSUs)
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 6.29 per share.	10 Jan 2025	2,695	0	-	6.3	16,952	Class A Common Stock
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 7.18 per share.	10 Jan 2025	2,692	7,074	-	7.2	19,329	Class A Common Stock
Xos Inc	George N. Mattson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,581	64,922	-		0	Common Stock
Greenwich LifeSciences Inc	Snehal S. Patel	Director, CEO and CFO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 12.51 per share.	10 Jan 2025	2,500	5,552,502	-	12.5	31,275	Common Stock
Veeco Instruments Inc	John P. Kiernan	SVP & CHIEF FINANCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 27.63 per share.	10 Jan 2025	2,500	75,142 (0%)	0%	27.6	69,075	Common Stock
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,500	75,875 (0%)	0%		0	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,500	2,500	-		-	Restricted Stock Units (RSUs)
fuboTV Inc	Alberto Horihuela Suarez	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.49 per share.	10 Jan 2025	2,496	1,450,193	-	0.5	1,223	Common Stock
fuboTV Inc	Alberto Horihuela Suarez	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,496	129,068	-		-	Employee Stock Option
Portland General Electric Co	Angelica Maria Espinosa	SVP, Chief Legal & Compliance	Grant, award, or other acquisition of securities at price $ 40.56 per share.	10 Jan 2025	2,465	16,728 (0%)	0%	40.6	99,980	Common Stock
Sera Prognostics Inc (Class A)	Austin Aerts	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 8.06 per share.	10 Jan 2025	2,431	283,325	-	8.1	19,594	Class A Common Stock
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 6.39 per share.	10 Jan 2025	2,415	1,814	-	6.4	15,432	Class A Common Stock
fuboTV Inc	Alberto Horihuela Suarez	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,405	55,286	-		-	Employee Stock Option
fuboTV Inc	Alberto Horihuela Suarez	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.99 per share.	10 Jan 2025	2,405	1,452,598	-	2.0	4,784	Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 167.36 per share.	10 Jan 2025	2,400	47,600	-	167.4	401,666	Class A Common Stock
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,320	0	-		-	Employee Stock Option (Right to Buy)
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share.	10 Jan 2025	2,320	278,100 (0%)	0%	9.5	21,924	Common Stock
Antero Midstream Corp	David H. Keyte	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,302	100,921 (0%)	0%		0	Common stock, par value $0.01 per share
Antero Midstream Corp	Janine J. Mcardle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,302	70,622 (0%)	0%		0	Common stock, par value $0.01 per share
Antero Midstream Corp	John C. Mollenkopf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,302	94,764 (0%)	0%		0	Common stock, par value $0.01 per share
Antero Midstream Corp	Peter A. Dea	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,302	57,006 (0%)	0%		0	Common stock, par value $0.01 per share
Antero Midstream Corp	W. Howard Keenan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,302	145,889 (0%)	0%		0	Common stock, par value $0.01 per share
Antero Midstream Corp	Brooks J. Klimley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,302	76,402 (0%)	0%		0	Common stock, par value $0.01 per share
Antero Midstream Corp	Nancy E. Chisholm	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	2,302	22,406 (0%)	0%		0	Common stock, par value $0.01 per share
Sera Prognostics Inc (Class A)	Robert G. Harrison	Chief Information Officer	Sale of securities on an exchange or to another person at price $ 6.47 per share.	10 Jan 2025	2,264	114,573	-	6.5	14,648	Class A Common Stock
Crown Castle	Edmond Chan	EVP and CIO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,247	3,987 (0%)	0%		0	Common Stock, $0.01 Par Value
Crown Castle	Edmond Chan	EVP and CIO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,247	9,027	-		-	Time RSUs
AAON Inc	Xerxes Gazder	Former CIO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.82 per share.	10 Jan 2025	2,240	2,442 (0%)	0%	34.8	77,997	Common Stock, par value $.004
AAON Inc	Xerxes Gazder	Former CIO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,240	0	-		-	Stock Option (Right to Buy)
Comstock Holding Co. Inc (Class A)	Christopher Guthrie	Chief Financial Officer & EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,232	121,709 (1%)	0%		0	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Christopher Guthrie	Chief Financial Officer & EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,232	6,694	-		-	Restricted Stock Units (RSUs)
Comstock Holding Co. Inc (Class A)	Timothy J. Steffan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,232	6,694	-		-	Restricted Stock Units (RSUs)
Comstock Holding Co. Inc (Class A)	Timothy J. Steffan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,232	109,307 (1%)	0%		0	Class A Common Stock, $0.01 par value
Corcept Therapeutics Inc	Daniel N. Swisher	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.13 per share.	10 Jan 2025	2,200	2,200 (0%)	0%	12.1	26,686	Common Stock
Corcept Therapeutics Inc	Daniel N. Swisher	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	2,200	8,400	-		-	Stock option (right to buy)
Corcept Therapeutics Inc	Daniel N. Swisher	Director	Sale of securities on an exchange or to another person at price $ 50.54 per share.	10 Jan 2025	2,200	0 (0%)	0%	50.5	111,188	Common Stock
Newmont	Bruce R Brook	Director	Sale of securities on an exchange or to another person at price $ 40.00 per share.	10 Jan 2025	2,077	52,070 (0%)	0%	40	83,080	Common Stock, $1.60 par value
Atlassian Corp (Class A)	Scott Farquhar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 242.25 per share.	10 Jan 2025	2,064	442,568 (0%)	0%	242.2	500,001	Class A Common Stock
Atlassian Corp (Class A)	Michael Cannon-Brookes	Director, CEO, Co-Founder, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 242.25 per share.	10 Jan 2025	2,063	440,475 (0%)	0%	242.2	499,758	Class A Common Stock
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	1,980	73,375 (0%)	0%		0	Class A Common Stock, $0.01 par value
Comstock Holding Co. Inc (Class A)	Christopher Clemente	Director, Chairman & CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jan 2025	1,980	0	-		-	Restricted Stock Units (RSUs)
Genesco Inc	Andrew I. Gray	Senior VP	Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.32 per share.	10 Jan 2025	1,951	59,972 (0%)	0%	41.3	80,615	Common Stock
United Therapeutics Corp	Christopher Patusky	Director	Sale of securities on an exchange or to another person at price $ 362.03 per share.	10 Jan 2025	1,930	2,101 (0%)	0%	362.0	698,724	Common Stock
Enovix Corp	Farhan Ahmad	Former Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.38 per share.	10 Jan 2025	1,919	55,001	-	11.4	21,838	Common Stock
Genpact Ltd	Donald J. Klunk	Chief Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share.	10 Jan 2025	1,897	12,913 (0%)	0%	43.3	82,216	Common Shares
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 7.18 per share.	10 Jan 2025	1,881	4,872	-	7.2	13,506	Class A Common Stock
Xos Inc	George N. Mattson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	1,863	64,204	-		0	Common Stock
iBio Inc	William D. Clark	Director	Purchase of securities on an exchange or from another person at price $ 2.72 per share.	10 Jan 2025	1,838	1,838 (0%)	0%	2.7	4,999	Common Stock
Sera Prognostics Inc (Class A)	Robert G. Harrison	Chief Information Officer	Sale of securities on an exchange or to another person at price $ 8.01 per share.	10 Jan 2025	1,837	116,837	-	8.0	14,714	Class A Common Stock
Meta Capex	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 616.65 per share.	10 Jan 2025	1,821	8,981 (0%)	0%	616.6	1,122,918	Class A Common Stock
Sera Prognostics Inc (Class A)	Joshua Phillips	Director	Sale of securities on an exchange or to another person at price $ 6.29 per share.	10 Jan 2025	1,814	0	-	6.3	11,410	Class A Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 171.20 per share.	10 Jan 2025	1,800	0	-	171.2	308,165	Class A Common Stock
Atlassian Corp (Class A)	Michael Cannon-Brookes	Director, CEO, Co-Founder, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 245.09 per share.	10 Jan 2025	1,794	443,294 (0%)	0%	245.1	439,683	Class A Common Stock
Atlassian Corp (Class A)	Scott Farquhar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 245.08 per share.	10 Jan 2025	1,794	429,192 (0%)	0%	245.1	439,682	Class A Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jan 10, 2025

Monitor US insider transactions and discover insider buying and selling of stocks on Jan 10, 2025.

The latest disclosure under SEC insider trading regulations was reported by Grindr Inc - Ordinary Shares - Class A., where the revocation of 8,448,334 Common Stock of common stock was executed . This transaction was reported to the Securities and Exchange Commission on Jan. 10, 2025.

Screeners based on Insider Trading parameters